Maturation alters cyclic nucleotide and relaxation responses to nitric oxide donors in ovine cerebral arteries

Biology of the Neonate

Volumn 83, Issue 2, 2003, Pages 123-135

  Nauli, Surya M ^a   White, Charles R ^a   Hull, Andrew D ^a   Pearce, William J ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebrovascular circulation; Cyclic adenosine monophosphate; Cyclic guanosine monophosphate; Sheep

Indexed keywords

CYCLIC AMP; CYCLIC GMP; GLYCERYL TRINITRATE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BRAIN ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; DRUG POTENCY; FEMALE; MATURATION; MEDIATOR RELEASE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SHEEP;

AGING; ANIMALS; ANIMALS, NEWBORN; CEREBRAL ARTERIES; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; NITRIC OXIDE DONORS; NITROGLYCERIN; NUCLEOTIDES, CYCLIC; OSMOLAR CONCENTRATION; S-NITROSO-N-ACETYLPENICILLAMINE; SHEEP; VASODILATION;

OVIS; OVIS ARIES;

EID: 0037269834     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067959     Document Type: Article

References (36)

1. Loskove JA, Frishman WH: Nitric oxide donors in the treatment of cardiovascular and pulmonary diseases. Am Heart J 1995;129:604-613.
2. Wiley KE, Davenport AP: Novel nitric oxide donors reverse endothelin-1-mediated constriction in human blood vessels. J Cardiovasc Pharmacol 2000;36:S151-S152.
3. Christou H, Van Marter LJ, Wessel DL, Allred EN, Kane JW, Thompson JE, Stark AR, Kourembanas S: Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med 2000;28:3722-3727.
4. Zellers TM, Vanhoutte PM: Endothelium-dependent relaxations of piglet pulmonary arteries augment with maturation. Pediatr Res 1991;30:176-180.
5. Pearce WJ, Hull AD, Long DM, White CR: Effects of maturation on cyclic GMP-dependent vasodilation in ovine basilar and carotid arteries. Pediatr Res 1994;36:25-33.
6. Michimata T, Imamura M, Mizuma H, Murakami M, Iriuchijima T: Sex and age differences in soluble guanylate cyclase activity in human platelets. Life Sci 1996;58:415-419.
7. Powel V, Moreira GA, O'Donnell DC, Filippov G, Block KD, Gordon JB: Maturational changes in ovine pulmonary vascular responses to inhaled nitric oxide. Pediatr Pulmonol 1999;27:157-166.
8. White RP, Vallance P, Markus HS: Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin Sci (Lond) 2000;99:555-560.
9. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739-749.
10. Kenkare SR, Benet LZ: Tolerance to nitroglycerin in rabbit aorta. Investigating the involvement of the mu isozyme of glutathione S-transferases. Biochem Pharmacol 1996;51:1357-1363.
11. Munzel T, Harrison DG: Evidence for a role of oxygen-derived free radicals and protein kinase C in nitrate tolerance. J Mol Med 1997;75:891-900.
12. Kowaluk EA, Poliszczuk R, Fung HL: Tolerance to relaxation in rat aorta: Comparison of an S-nitrosothiol with nitroglycerin. Eur J Pharmacol 1987;144:379-383.
13. Zierhut W, Ball HA: Prevention of vascular nitroglycerin tolerance by inhibition of protein kinase C. Br J Pharmacol 1996;119:3-5.
14. Ignarro LJ, Cirino G, Casini A, Napoli C: Nitric oxide as a signaling molecule in the vascular system: An overview. J Cardiovasc Pharmacol 1999;34:879-886.
15. Francis SH, Turko IV, Corbin JD: Cyclic nucleotide phosphodiesterases: Relating structure and function. Prog Nucleic Acid Res Mol Biol 2000;65:1-52.
16. Francis SH, Corbin JD: Cyclic nucleotide-dependent protein kinases: Intracellular receptors for cAMP and cGMP action. Crit Rev Clin Lab Sci 1999;36:275-328.
17. 2+ sensitivity in ovine cranial arteries. Am J Physiol Heart Circ Physiol 2001;280:H1019-H1028.
18. White CR, Pearce WJ: Effects of maturation on cyclic GMP metabolism in ovine carotid arteries. Pediatr Res 1996;39:25-31.
19. Pelligrino DA, Wang Q: Cyclic nucleotide crosstalk and the regulation of cerebral vasodilation. Prog Neurobiol 1998;56:1-18.
20. Soderling SH, Beavo JA: Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions. Curr Opin Cell Biol 2000;12:174-179.
21. Dhanakoti SN, Gao Y, Nguyen MQ, Raj JU: Involvement of cGMP-dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP. J Appl Physiol 2000;88:1637-1642.
22. Pearce WJ, Hull AD, Long DM, Longo LD: Developmental changes in ovine cerebral artery composition and reactivity. Am J Physiol 1991;261:R458-R465.
23. Pearce WJ, Ashwal S, Cuevas J: Direct effects of graded hypoxia on intact and denuded rabbit cranial arteries. Am J Physiol 1989;257:H824-H833.
24. Elliott CF, Pearce WJ: Effects of maturation on cell water, protein, and DNA content in ovine cerebral arteries. J Appl Physiol 1995;79:831-837.
25. Pearce WJ, Longo LD: Developmental aspects of endothelial function. Semin Perinatol 1991;15:40-48.
26. Parfenova H, Massie V, Leffler CW: Developmental changes in endothelium-derived vaso-relaxant factors in cerebral circulation. Am J Physiol Heart Circ Physiol 2000;278:H780-H788.
27. White CR, Hao X, Pearce WJ: Maturational differences in soluble guanylate cyclase activity in ovine carotid and cerebral arteries. Pediatr Res 2000;47:369-375.
28. Sellke FW, Myers PR, Bates JN, Harrison DG: Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am J Physiol 1990;258:H515-H520.
29. Martinez-Orgado J, Salaices M, Rodriguez-Martinez MA, Sanchez-Ferrer CF, Marin J: Role of nitric oxide on the endothelium-dependent vasodilation in newborn piglet cerebral arteries. Gen Pharmacol 1994;25:899-902.
30. Zuckerman SL, Armstead WM, Hsu P, Shibata M, Leffler CW: Age dependence of cerebrovascular response mechanisms in domestic pigs. Am J Physiol 1996;271:H535-H540.
31. Wilderman MJ, Armstead WM: Role of endothelial nitric oxide synthase in hypoxia-induced pial artery dilation. J Cereb Blood Flow Metab 1998;18:531-538.
32. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA: Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000;52:375-414.
33. Kostromin AP, Berdyshev GD, Demidov SV, Kuibeda VV: Age-associated changes in content of cyclic adenosine-3′,5′-monophosphate (cAMP), cyclic guanosine-3′,5′-monophosphate (cGMP) and in activity of phosphodiesterase-cAM (pDE-cAM) in spleen T-lymphocytes from C3HA mice. ZFA 1984;39:351-355.
34. Wolfe L, Corbin JD, Francis SH: Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta. J Biol Chem 1989;264:7734-7741.
35. Polson JB, Strada SJ: Cyclic nucleotide phosphodisterases and vascular smooth muscle. Annu Rev Pharmacol Toxicol 1996;36:403-427.
36. Lugnier C, Keravis T, Eckly-Michel A: Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel. J Physiol Pharmacol 1999;50:639-652.